PURE Bioscience, Inc. (PURE)
OTCMKTS: PURE · Delayed Price · USD
0.0700
0.00 (0.00%)
Apr 25, 2024, 10:50 AM EDT - Market open
PURE Bioscience Income Statement
Financials in millions USD. Fiscal year is August - July.
Millions USD. Fiscal year is Aug - Jul.
| Year | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 - 1996 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1.88 | 1.85 | 3.93 | 6.92 | 1.91 | 1.77 | 1.83 | 1.29 | 0.73 | 0.55 | Upgrade
|
| Revenue Growth (YoY) | 1.30% | -52.81% | -43.23% | 262.34% | 7.61% | -3.11% | 42.05% | 76.82% | 32.55% | -32.93% | Upgrade
|
| Cost of Revenue | 0.91 | 0.85 | 1.85 | 2.9 | 0.73 | 0.76 | 0.76 | 0.44 | 0.29 | 0.34 | Upgrade
|
| Gross Profit | 0.97 | 1 | 2.08 | 4.02 | 1.18 | 1.01 | 1.07 | 0.85 | 0.44 | 0.21 | Upgrade
|
| Selling, General & Admin | 4.3 | 4.11 | 4.05 | 3.7 | 6.42 | 7.59 | 6.3 | 6.98 | 7.29 | 8.32 | Upgrade
|
| Research & Development | 0.3 | 0.32 | 0.34 | 0.32 | 0.35 | 0.46 | 0.78 | 0.93 | 0.79 | 1.03 | Upgrade
|
| Other Operating Expenses | -0 | 0 | -0 | 0.01 | 0 | 0.03 | 0 | 0 | 0 | 0 | Upgrade
|
| Operating Expenses | 4.6 | 4.43 | 4.39 | 4.02 | 6.77 | 8.05 | 7.08 | 7.91 | 8.08 | 9.35 | Upgrade
|
| Operating Income | -3.94 | -3.43 | -2.31 | 0.01 | -5.59 | -7.04 | -6.01 | 0.25 | -7.64 | -9.15 | Upgrade
|
| Interest Income | 0.01 | 0.01 | 0 | 0.01 | 0.01 | 0 | 0 | 0 | 0 | 0 | Upgrade
|
| Interest Expense | 0.01 | 0.01 | 0 | 0.01 | 0.01 | 0.01 | -0.01 | -0.01 | -0.01 | -0.01 | Upgrade
|
| Other Expense / Income | 0.01 | 0.07 | 0.01 | 0.01 | 0.97 | 0.39 | 0.26 | 14.63 | -0.01 | 1.91 | Upgrade
|
| Pretax Income | -3.96 | -3.49 | -2.32 | 0 | -6.55 | -7.44 | -6.26 | -14.37 | -7.63 | -11.05 | Upgrade
|
| Income Tax | 0.01 | 0.01 | 0 | 0.01 | 0.01 | 0.03 | 0.26 | 7.31 | -0.01 | 1.9 | Upgrade
|
| Net Income | -3.96 | -3.5 | -2.32 | -0.01 | -6.56 | -7.48 | -6.52 | -21.69 | -7.61 | -12.95 | Upgrade
|
| Shares Outstanding (Basic) | 111 | 89 | 87 | 82 | 73 | 67 | 63 | 57 | 40 | 26 | Upgrade
|
| Shares Outstanding (Diluted) | 111 | 89 | 87 | 85 | 73 | 67 | 63 | 57 | 40 | 26 | Upgrade
|
| Shares Change | 25.41% | 1.91% | 3.03% | 16.10% | 8.33% | 5.96% | 11.72% | 42.97% | 55.21% | 136.29% | Upgrade
|
| EPS (Basic) | -0.04 | -0.04 | -0.03 | -0.00 | -0.09 | -0.11 | -0.10 | -0.38 | -0.19 | -0.51 | Upgrade
|
| EPS (Diluted) | -0.04 | -0.04 | -0.03 | -0.00 | -0.09 | -0.11 | -0.10 | -0.38 | -0.19 | -0.51 | Upgrade
|
| Free Cash Flow | -3.31 | -2.5 | -1.69 | 0.61 | -3 | -3.92 | -4.79 | -5.4 | -6.17 | -6.44 | Upgrade
|
| Free Cash Flow Per Share | -0.03 | -0.03 | -0.02 | 0.01 | -0.04 | -0.06 | -0.08 | -0.09 | -0.16 | -0.25 | Upgrade
|
| Gross Margin | 51.73% | 53.97% | 52.84% | 58.13% | 61.86% | 56.99% | 58.49% | 65.79% | 60.91% | 37.45% | Upgrade
|
| Operating Margin | -210.07% | -184.84% | -58.85% | 0.13% | -292.77% | -396.96% | -328.13% | 19.16% | -1048.01% | -1663.27% | Upgrade
|
| Profit Margin | -211.03% | -188.72% | -59.05% | -0.09% | -343.69% | -421.36% | -355.98% | -1682.31% | -1044.44% | -2354.91% | Upgrade
|
| Free Cash Flow Margin | -176.40% | -134.86% | -42.98% | 8.83% | -157.31% | -221.03% | -261.50% | -418.62% | -846.36% | -1170.55% | Upgrade
|
| Effective Tax Rate | - | - | - | 250.00% | - | - | - | - | - | - | Upgrade
|
| EBITDA | -3.52 | -3.21 | -2.14 | 0.2 | -5.35 | -6.73 | -5.48 | 0.47 | -7.46 | -7.01 | Upgrade
|
| EBITDA Margin | -187.27% | -173.34% | -54.57% | 2.91% | -280.09% | -379.48% | -299.40% | 36.15% | -1022.63% | -1274.18% | Upgrade
|
| Depreciation & Amortization | 0.12 | 0.21 | 0.17 | 0.19 | 0.24 | 0.29 | 0.28 | 0.22 | 0.21 | 0.25 | Upgrade
|
| EBIT | -3.63 | -3.43 | -2.32 | 0.01 | -5.59 | -7.02 | -5.76 | 0.25 | -7.66 | -7.26 | Upgrade
|
| EBIT Margin | -193.50% | -184.84% | -58.95% | 0.13% | -292.72% | -395.55% | -314.47% | 19.16% | -1050.89% | -1319.27% | Upgrade
|
Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.